Recent advances in the endoscopic assessment of ulcerative colitis
暂无分享,去创建一个
[1] S. Kudo,et al. 575 Narrow-Band Imaging Efficiency for Evaluation of Mucosal Healing/ Relapse of Ulcerative colitis , 2016 .
[2] E. Dekker,et al. 571 Biopsies Taken From Mucosa Surrounding Dysplastic Lesions Found During IBD Surveillance Show a Low Rate of Dysplasia , 2016 .
[3] R. Panaccione,et al. 625 Real Time Histology at Endoscopy - Virtual Electronic Chromoendoscopy and Probe Confocal Laser Endomicroscopy Can Assess Fine Details of Inflammatory Changes in Ulcerative Colitis Patients , 2016 .
[4] Subrata Ghosh,et al. Mucosal Healing - How Deep Is Enough? , 2016, Digestive Diseases.
[5] Ditlev Nytoft Rasmussen,et al. Confocal Laser Endomicroscopy in Inflammatory Bowel Disease--A Systematic Review. , 2015, Journal of Crohn's & colitis.
[6] L. Stitt,et al. Development and validation of a histological index for UC , 2015, Gut.
[7] S. Travis,et al. Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials , 2015, Inflammatory bowel diseases.
[8] T. Murdoch,et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target , 2015, The American Journal of Gastroenterology.
[9] P. Rutgeerts,et al. Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease , 2015, Gut.
[10] G. Kaplan,et al. Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings , 2015, Endoscopy.
[11] A. Barkun,et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. , 2015, Gastroenterology.
[12] L. Peyrin-Biroulet,et al. An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitis , 2014, Gut.
[13] S. Travis,et al. Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative. , 2014, Journal of Crohn's & colitis.
[14] F. Rizzello,et al. Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD). , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[15] L. Peyrin-Biroulet,et al. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[16] G. D'Haens,et al. A Systematic Review of the Measurement of Endoscopic Healing in Ulcerative Colitis Clinical Trials: Recommendations and Implications for Future Research , 2014, Inflammatory bowel diseases.
[17] R. Ji,et al. Use of confocal laser endomicroscopy to predict relapse of ulcerative colitis , 2014, BMC Gastroenterology.
[18] F. Rizzello,et al. P452 Increasing interobserver agreement on IBD endoscopic scoring systems: results from the IGIBDEndo educational program , 2014 .
[19] N. Yahagi,et al. Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease. , 2014, Canadian journal of gastroenterology & hepatology.
[20] F. Guglielmi,et al. Definition and evaluation of mucosal healing in clinical practice. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[21] Yutaka Saito,et al. Endoscopic submucosal dissection in the colorectum: Feasibility in the Canadian setting. , 2013, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[22] D. Altman,et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. , 2013, Gastroenterology.
[23] A. Cheifetz,et al. Histologic markers of inflammation in patients with ulcerative colitis in clinical remission. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[24] P. Rutgeerts,et al. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis. , 2013, Gastroenterology.
[25] N. Yahagi,et al. Colorectal endoscopic submucosal dissection: Is it suitable in western countries? , 2013, Journal of gastroenterology and hepatology.
[26] R. Panaccione,et al. Advances in novel diagnostic endoscopic imaging techniques in inflammatory bowel disease. , 2013, Inflammatory bowel diseases.
[27] D. Hommes,et al. Adenomas in Patients with Inflammatory Bowel Disease Are Associated with an Increased Risk of Advanced Neoplasia , 2013, Inflammatory bowel diseases.
[28] A. Zinsmeister,et al. Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[29] Toshio Uraoka,et al. COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION IN JAPAN AND WESTERN COUNTRIES , 2012, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.
[30] A. Zinsmeister,et al. Outcome of Sporadic Adenomas and Adenoma‐Like Dysplasia in Patients with Ulcerative Colitis Undergoing Polypectomy§† , 2012, Inflammatory bowel diseases.
[31] A Repici,et al. Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: a systematic review , 2012, Endoscopy.
[32] N. Harpaz,et al. Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location. , 2011, Gastrointestinal endoscopy.
[33] D. Altman,et al. Translational Gastroenterology , 2011 .
[34] Martin Goetz,et al. New imaging techniques and opportunities in endoscopy , 2011, Nature Reviews Gastroenterology &Hepatology.
[35] C. O'Morain,et al. Review article: defining remission in ulcerative colitis , 2011, Alimentary pharmacology & therapeutics.
[36] Subrata Ghosh,et al. Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease , 2011, Therapeutic advances in gastroenterology.
[37] Simon K Lo,et al. The learning curve of in vivo probe-based confocal laser endomicroscopy for prediction of colorectal neoplasia. , 2009, Gastrointestinal endoscopy.
[38] B. Korelitz. Mucosal healing as an index of colitis activity: back to histological healing for future indices. , 2010, Inflammatory bowel diseases.
[39] Xiu-Li Zuo,et al. Classification of Inflammation Activity in Ulcerative Colitis by Confocal Laser Endomicroscopy , 2010, The American Journal of Gastroenterology.
[40] Mitsuhiro Fujishiro,et al. Novel image-enhanced endoscopy with i-scan technology. , 2010, World journal of gastroenterology.
[41] A. Chak,et al. I-Scan: chromoendoscopy without the hassle? , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[42] Paul Fockens,et al. Probe-based confocal laser endomicroscopy. , 2009, Gastroenterology.
[43] M. Esaki,et al. Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation , 2009, International Journal of Colorectal Disease.
[44] O. Maeda,et al. Confocal endomicroscopy in patients with ulcerative colitis , 2008, Journal of gastroenterology and hepatology.
[45] M. Vatn,et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. , 2007, Gastroenterology.
[46] R. Kiesslich,et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. , 2007, Gastroenterology.
[47] Paul Rutgeerts,et al. Infliximab for induction and maintenance therapy for ulcerative colitis. , 2005, The New England journal of medicine.
[48] A. Cohen,et al. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. , 2005, The New England journal of medicine.
[49] R. Odze,et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[50] A. Öst,et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis , 2000, Gut.
[51] C. Kleer,et al. Endoscopic and histological patchiness in treated ulcerative colitis. , 1999 .
[52] C. Bernstein,et al. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. , 1995, Gastrointestinal endoscopy.
[53] W. Tremaine,et al. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.
[54] J. H. Baron,et al. Variation Between Observers in Describing Mucosal Appearances in Proctocolitis* , 1964, British medical journal.
[55] C. FordAlexander,et al. ULCERATIVE colitis. , 1997, Journal of the American Medical Association.
[56] S. Truelove,et al. Cortisone in Ulcerative Colitis , 1954 .